Day One Biopharmaceuticals Stock Statistic Functions Beta

DAWN Stock  USD 12.53  0.11  0.87%   
Day One statistic functions tool provides the execution environment for running the Beta function and other technical functions against Day One. Day One value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of statistic functions indicators. As with most other technical indicators, the Beta function function is designed to identify and follow existing trends. Day One statistical functions help analysts to determine different price movement patterns based on how price series statistical indicators change over time. Please specify Time Period to run this model.

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Day One Biopharmaceu correlated with the market. If Beta is less than 0 Day One generally moves in the opposite direction as compared to the market. If Day One Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Day One Biopharmaceu is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Day One is generally in the same direction as the market. If Beta > 1 Day One moves generally in the same direction as, but more than the movement of the benchmark.

Day One Technical Analysis Modules

Most technical analysis of Day One help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Day from various momentum indicators to cycle indicators. When you analyze Day charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Day One Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Day One Biopharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Day One Biopharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Day Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Day One's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Day One's intrinsic value. In addition to deriving basic predictive indicators for Day One, we also check how macroeconomic factors affect Day One price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Current Ratio33.4320.9412.7222.7
Net Debt To EBITDA3.920.61.121.83
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Day One's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
10.2612.5914.92
Details
Intrinsic
Valuation
LowRealHigh
11.2819.3421.67
Details
10 Analysts
Consensus
LowTargetHigh
35.2938.7843.05
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.39-0.2-0.06
Details

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Day One Biopharmaceu offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Day One's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Day One Biopharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Day One Biopharmaceuticals Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Day One Biopharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Day One. If investors know Day will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Day One listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.97)
Revenue Per Share
1.144
Return On Assets
(0.25)
Return On Equity
(0.18)
The market value of Day One Biopharmaceu is measured differently than its book value, which is the value of Day that is recorded on the company's balance sheet. Investors also form their own opinion of Day One's value that differs from its market value or its book value, called intrinsic value, which is Day One's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Day One's market value can be influenced by many factors that don't directly affect Day One's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Day One's value and its price as these two are different measures arrived at by different means. Investors typically determine if Day One is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Day One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.